The loss of this patent is a modest negative for Nike's wearables IP portfolio but is unlikely to materially affect revenue or earnings given the narrow scope of the patent and the nonprecedential nature of the ruling. Monitor for any further IPR petitions or district court cases involving related Nike patents against lululemon or other competitors.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 6 $41.56entry
- T+1 · 3mo ago −0.71%α −1.33% · $41.26
- T+5 · 3mo ago −1.83%α −3.05% · $40.80
- T+20 · 3mo ago −6.71%α −7.31% · $38.77
- T+60 · 18d ago −6.95%α −5.53% · $38.67
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Federal Circuit affirmed the PTAB's final written decision in IPR2023-00438, finding all challenged claims (1–5, 7, 9, 12–14, 17–19) of Nike's U.S. Patent No. 8,620,413 unpatentable as anticipated or obvious over prior art. This is a loss for Nike in its patent dispute with lululemon, removing a patent covering heart-rate-zone exercise prompting in wearable devices. The ruling is nonprecedential and limited to this specific patent, but it eliminates a potential infringement remedy against a key competitor in the athletic wearables space.
Court Ruling Details
Key Facts
- The Federal Circuit affirmed the PTAB's invalidation of all challenged claims of Nike's '413 patent covering heart-rate-zone exercise prompting in wearable devices.
- The ruling is nonprecedential and limited to this specific IPR, not creating binding precedent for other patents.
- Lululemon was awarded costs.
- The '413 patent was found anticipated by Amano (claims 1, 5, 7, 12, 17) and obvious over Amano in combination with Gorman or Flach (remaining claims).
Financial Impact
No damages awarded. The ruling eliminates potential licensing revenue or injunction leverage against lululemon for this specific patent. Financial impact is limited to the loss of one patent in a single IPR.
Risk Factors
- No direct financial damages or injunction resulted from this ruling.
- The ruling is nonprecedential, limiting its impact beyond this specific patent and party.
- Nike's remaining patent portfolio covering wearable technology is unaffected by this decision.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-ab1f8efe5e-NKE |
Track record
33 reports on NKE
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +26.31% at T+60 after the Feb 28, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $37.91 Now $38.26 +0.92% settles Feb 12
- Nov 10, 20266d ago ANALYST-UPGRADE Neutral 1/10 Entry $38.67 Now $38.26 −1.06% settles Feb 8
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $38.67 Now $38.26 −1.06% settles Feb 8
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $38.67 Now $38.26 −1.06% settles Jan 28
- Oct 20, 202627d ago Institutional Cluster Mixed 3/10 Entry $37.53 Now $38.26 +1.95% settles Jan 19
- Oct 2, 20266w ago ANALYST-UPGRADE Bullish 4/10 Entry $33.96 Now $38.26 +12.66% settles Dec 30
- Sep 25, 20267w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Sep 22, 20267w ago ANALYST-UPGRADE Neutral 1/10 Entry $36.10 Now $38.26 +5.98% settles Dec 16
- Sep 14, 20269w ago ANALYST-DOWNGRADE Bearish 5/10 Entry $37.05 Now $38.26 −3.27% settles Dec 8
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $36.80 Now $38.26 +3.97% settles Dec 7
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers